Results 161 to 170 of about 1,100,787 (194)

A review of a novel, Bruton’s tyrosine kinase inhibitor, ibrutinib

Journal of Oncology Pharmacy Practice, 2016
Chung-Shien Lee, Sara S Kim
exaly  

Inhibitors of Bruton's tyrosine kinase

2018
LEE SEUNG, YAMAMOTO SHINGO
openaire   +5 more sources

A highly sensitive LC-MS/MS method to determine novel Bruton's tyrosine kinase inhibitor spebrutinib: application to metabolic stability evaluation

Royal Society Open Science, 2019
Adnan Kadı, Mohamed W Attwa, Ali Saber Abdelhameed   +2 more
exaly  

What Causes Bruton Tyrosine Kinase Inhibitor Resistance in Mantle Cell Lymphoma and How Should We Treat Such Patients?

Hematology/Oncology Clinics of North America, 2020
Simon A Rule, Toby A Eyre, Rory McCulloch   +2 more
exaly  

Inhibitors of Bruton's tyrosine kinase

2013
BROTHERTON-PLEISS CHRISTINE, LOPEZ-TAPIA FRANCISCO JAVIER, LOU YAN   +2 more
  +7 more sources

Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemia

Leukemia and Lymphoma, 2013
Jacqueline Barrientos
exaly  

PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies

Expert Opinion on Investigational Drugs, 2012
Jorge Castillo
exaly  

Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model

Heliyon, 2019
Ramzi M Mohammad, Asfar S Azmi, Irfana Muqbil   +2 more
exaly  

Inhibitors of bruton's tyrosine kinase

2009
DEWDNEY NOLAN JAMES, KONDRU RAMA K, LOE BRADLEY E, LOU YAN, MCINTOSH JOEL, OWENS TIMOTHY D, SOTH MICHAEL   +6 more
openaire   +8 more sources

The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review

European Journal of Medicinal Chemistry, 2018
Chengyuan Liang, Suresh Thareja, Xiaodong Ren   +2 more
exaly